 "Pfizer")
Drug firm Pfizer on Friday reported 83 per cent decline in consolidated net profit at Rs 33 crore for June quarter 2022-23.
The company had logged a net profit of Rs 200 crore in April-June period a year ago.
Revenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period.
The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.
Shares of the company settled at Rs 4,230 apiece, down 0.72 per cent, on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
